BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17145168)

  • 1. Induction of TIMP-1 and HSP47 synthesis in primary keloid fibroblasts by exogenous nitric oxide.
    Hsu YC; Wang LF; Chien YW; Lee WR
    J Dermatol Sci; 2007 Jan; 45(1):37-44. PubMed ID: 17145168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous nitric oxide stimulated collagen type I expression and TGF-beta1 production in keloid fibroblasts by a cGMP-dependent manner.
    Hsu YC; Hsiao M; Chien YW; Lee WR
    Nitric Oxide; 2007 Mar; 16(2):258-65. PubMed ID: 17052928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
    Fujiwara M; Muragaki Y; Ooshima A
    Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid.
    Hsu YC; Chen MJ; Yu YM; Ko SY; Chang CC
    Arch Dermatol Res; 2010 Dec; 302(10):717-24. PubMed ID: 20717830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous nitric oxide enhances the synthesis of type I collagen and heat shock protein 47 by normal human dermal fibroblasts.
    Obayashi K; Akamatsu H; Okano Y; Matsunaga K; Masaki H
    J Dermatol Sci; 2006 Feb; 41(2):121-6. PubMed ID: 16171977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heat shock protein 47 on collagen accumulation in keloid fibroblast cells.
    Chen JJ; Zhao S; Cen Y; Liu XX; Yu R; Wu DM
    Br J Dermatol; 2007 Jun; 156(6):1188-95. PubMed ID: 17535221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS; Wu PH; Fang AH; Lan CC
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, keloid.
    Naitoh M; Hosokawa N; Kubota H; Tanaka T; Shirane H; Sawada M; Nishimura Y; Nagata K
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1316-22. PubMed ID: 11162672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.
    Nakayama S; Mukae H; Sakamoto N; Kakugawa T; Yoshioka S; Soda H; Oku H; Urata Y; Kondo T; Kubota H; Nagata K; Kohno S
    Life Sci; 2008 Jan; 82(3-4):210-7. PubMed ID: 18093617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture.
    Naim R; Naumann A; Barnes J; Sauter A; Hormann K; Merkel D; Aust W; Braun T; Bloching M
    Aesthetic Plast Surg; 2008 Mar; 32(2):346-52. PubMed ID: 18087663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
    Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
    Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts.
    Bran GM; Goessler UR; Baftiri A; Hormann K; Riedel F; Sadick H
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):66-71. PubMed ID: 20620621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the expression of heat shock protein 47 and its correlation to collagen].
    Chen J; Cen Y; Xu X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jan; 19(1):31-4. PubMed ID: 15704838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation.
    Hsu YC; Hsiao M; Wang LF; Chien YW; Lee WR
    Nitric Oxide; 2006 Jun; 14(4):327-34. PubMed ID: 16517189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
    Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
    J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of heat shock protein 47, a collagen-binding chaperone, in lacrimal gland pathology in patients with cGVHD.
    Ogawa Y; Razzaque MS; Kameyama K; Hasegawa G; Shimmura S; Kawai M; Okamoto S; Ikeda Y; Tsubota K; Kawakami Y; Kuwana M
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1079-86. PubMed ID: 17325149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and function of sphingosine kinases 1 and 2 in human keloid fibroblasts].
    Zhang J; Xu B; Liu ZZ; Wang W; Wang LX; Zhang JX; Cai JL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):533-7. PubMed ID: 19567073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide: Is it the culprit for the continued expansion of keloids?
    Hsieh SC; Lai CS; Chang CH; Yen JH; Huang SW; Feng CH; Chen YW; Li ZY
    Eur J Pharmacol; 2019 Jul; 854():282-288. PubMed ID: 31034822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.